Cordyceps Ophiocordyceps sinensis (Berk.) G.H. Sung, J.M. Sung, Hywel-Jones & Spatafora; Cordyceps militaris (L.) Fr.
Also called: Cordyceps sinensis, caterpillar fungus, aweto, Cs-4, Cordyceps militaris
Cordyceps refers to parasitic fungi used in traditional Chinese medicine. Wild Ophiocordyceps sinensis grows on moth larvae; most supplements instead contain Cs-4, a laboratory-grown form, or Cordyceps militaris, sold as capsules, tablets, powders and beverages.
- Category
- Mushroom
- Forms
- Wild fungus–larva complex (O. sinensis); laboratory-grown mycelium (Cs-4); C. militaris preparations
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2026 meta-analysis (Front Pharmacol) included 11 RCTs (920 adults with nephrotic syndrome) of oral Bailing Capsule, a Chinese pharmacopoeial drug whose sole active ingredient is fermented Hirsutella sinensis mycelium powder (strain CS-C-Q80, the asexual form of O. sinensis), alone or added to conventional therapy, versus conventional therapy. [10]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CImmune system and infection1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Kidney function in chronic kidney disease (C. sinensis preparations) | C | Cochrane 2014: 22 studies (1,746 participants). With conventional treatment, cordyceps lowered serum creatinine (MD −60.76 µmol/L) and proteinuria in people not on dialysis; evidence was low quality. [3] |
| Kidney transplant recipients (C. sinensis preparations) | C | Cochrane 2015: 5 studies (447 participants). Versus azathioprine, no difference in graft or patient survival, with possibly fewer acute rejections; all studies had unclear risk of bias. [4] |
| Endurance performance in trained cyclists (Cs-4) | C | RCT in 22 endurance-trained male cyclists: a Cs-4 product (labeled Cordyceps sinensis) 3 g/day for 5 weeks did not change VO2peak, ventilatory threshold or time-trial performance. [5] |
| Exercise capacity in healthy older adults (Cs-4) | C | Pilot RCT in 20 adults aged 50–75: Cs-4 333 mg three times daily for 12 weeks raised metabolic and ventilatory thresholds; VO2max did not change in either group. [6] |
| High-intensity exercise (C. militaris mushroom blend) | C | RCT in 28 young adults: a 4 g/day blend containing C. militaris did not change outcomes after 1 week; in 10 who continued 3 weeks, VO2max improved versus placebo. [7] |
| Immune measures in healthy men (C. militaris) | C | RCT in 79 healthy Korean men: 1.5 g/day ethanol-treated C. militaris for 4 weeks increased NK cell activity and lymphocyte proliferation more than placebo. [8] |
Main constituents: Cordycepin [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Commercial products recommend 0.5 to 4 grams daily; trial doses ranged from about 333 mg three times daily to 3 g daily. [2]
- C. militaris 1.5 g/day for 4 weeks (immune trial). [8]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
NIH LiverTox (last update July 23, 2026): likelihood score E, "unlikely cause of clinically apparent liver injury".
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines2 listed
Anticoagulants and antiplatelet drugs (e.g. warfarin); Insulin and other blood-sugar-lowering drugs
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications8 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- LiverTox likelihood score E (unlikely cause of clinically apparent liver injury): cordyceps extracts are generally well tolerated, with no published cases of acute liver injury. [2]
- A 2023 case report described hepatoportal sclerosis in an 81-year-old woman after about five years of use; the link to cordyceps is uncertain. [2]
- Mild effects reported: abdominal discomfort, diarrhea, dry mouth, nausea, poor appetite and rash. [2]
- Case report: excessive bleeding after tooth extraction in a person taking cordyceps daily as a tonic. [1]
- Animal studies showed proliferation of red blood cell progenitors, so MSK advises that it not be used by people with myelogenous-type cancers. It stimulated testosterone production in mice; effects in humans are unknown. [1]
Interactions
| With | What happens |
|---|---|
| Diabetes medications and insulin | Laboratory studies suggest additive blood-sugar-lowering effects; clinical relevance has not been determined. [1] |
| Anticoagulants and antiplatelet drugs | Laboratory studies show inhibition of platelet aggregation, which may increase the effects of these drugs; one bleeding case has been reported. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: sold over the counter as an herbal and dietary supplement; LiverTox notes its purported benefits have not been convincingly shown in human trials. [2]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Cordycepin (3'-deoxyadenosine), polysaccharides and sugars Nucleoside analogue; polysaccharides [P4]
- Cordycepin is often absent from O. sinensis or present only in trace amounts; a proposed quality index sums N6-(2-hydroxyethyl)adenosine, adenosine and cordycepin (0–0.071% in mycelium-based products vs 0.071–0.100% in wild cordyceps) Nucleosides [P6]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 8 entries naming Cordyceps (six naming Cordyceps sinensis, two naming Cordyceps cicadae) (earliest NDI 45 submitted 1998-11-18; most recent NDI 1203 submitted 2021-04-27). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. No entry names Cordyceps militaris or Ophiocordyceps. [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of cordyceps (Ophiocordyceps sinensis or Cordyceps militaris) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- NIH LiverTox (last update July 23, 2026): likelihood score E, "unlikely cause of clinically apparent liver injury". [P4]
Interactions with medicines
- Anticoagulants and antiplatelet drugs (e.g. warfarin): MSK: laboratory studies suggest cordyceps inhibits platelet aggregation and may increase the effects of these drugs; a case report describes excessive bleeding after tooth extraction associated with daily cordyceps use. [P5]
- Insulin and other blood-sugar-lowering drugs: MSK: laboratory studies suggest additive effects; clinical relevance has yet to be determined. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- ABC-AHP-NCNPR Botanical Adulterants Prevention Bulletin: Cordyceps (October 2024): because of its value, rarity in the wild and difficulty of cultivation, adulteration and substitution of O. sinensis frequently occur. Reported forms: other fungal species sold as O. sinensis (e.g. Cordyceps militaris, Tolypocladium inflatum, Sanghuangporus sanghuang), mycelium or mycelium biomass labeled as fruiting body, excess grain substrate, undeclared fillers, plant parts or flour models glued to caterpillars, and reports of fruiting bodies soaked in concentrated lead or aluminum sulfate solutions to increase weight. The ingredient Cs-4 is made from Samsoniella hepiali (syn. Paecilomyces hepiali), which is sold in the US as a "strain of C. sinensis" although the two species are only distantly related genetically. [P6]
- Wu et al. (1996) reported two cases of lead poisoning caused by contaminated cordyceps; lead content in the cordyceps powder was as high as 20,000 ppm. [P7]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
- DNA identification (e.g. ITS barcode sequencing) plus chemical analysis — BAPP (2024) recommends that authenticity of any cordyceps raw material or finished product be determined by both DNA and chemical analysis, because substitution with other fungi is common and contaminating fungi can outgrow the intended culture. [P6]
- Starch / alpha-glucan content (residual substrate) — BAPP (2024) reports mycelium products composed mainly of starch or maltodextrin, residual grain of 15–80% depending on substrate, and over 82% alpha-glucans (relative to total glucans) in three of four mycelium products tested in one study. [P6]
- Lead (heavy metal) assay — Wu et al. (1996) reported two cases of lead poisoning caused by contaminated cordyceps, with lead in the cordyceps powder as high as 20,000 ppm. [P7]
Supply and conservation
- IUCN Red List: Vulnerable (VU), via GBIF species API, retrieved 2026-10-29 (Ophiocordyceps sinensis). [P8]
- BAPP (2024): wild cordyceps (O. sinensis) is collected on the Tibetan (Qinghai-Tibet) plateau; wild material typically costs over $25,000 per kilogram, while 2018 wholesale prices for Cs-4 made from mycelium were $8–10/kg. Cordyceps militaris fruiting body is the primary cordyceps fruiting body cultivated on a commercial scale. [P6]
- LiverTox: most commercial cordyceps supplements in current use are not derived from the natural fungus. [P4]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- NIH LiverTox. Cordyceps (last update July 23, 2026), 2026-07-23. ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Cordyceps (last updated February 10, 2022), 2022-02-10. mskcc.org
- Hobbs C, Upton R, Gafner S. Cordyceps (Ophiocordyceps sinensis). Botanical Adulterants Prevention Bulletin. ABC-AHP-NCNPR Botanical Adulterants Prevention Program (October 2024), 2024-10. umb.herbalgram.org
- Wu TN, et al. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ 1996;182(1-3):193-5 (PMID 8854946), 1996-04-05. pubmed.ncbi.nlm.nih.gov
- GBIF species API: IUCN Red List category for Ophiocordyceps sinensis, 2026-10-29. api.gbif.org
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Cordyceps (last updated February 10, 2022), 2022-02-10. mskcc.org
- NIH LiverTox. Cordyceps (last update July 23, 2026), 2026-07-23. ncbi.nlm.nih.gov
- Zhang HW, et al. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev 2014;(12):CD008353, 2014-12-18. pubmed.ncbi.nlm.nih.gov
- Hong T, et al. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Cochrane Database Syst Rev 2015;(10):CD009698, 2015-10-12. pubmed.ncbi.nlm.nih.gov
- Parcell AC, et al. Cordyceps sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab 2004;14(2):236-42, 2004-04. pubmed.ncbi.nlm.nih.gov
- Chen S, et al. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med 2010;16(5):585-90, 2010-05. pubmed.ncbi.nlm.nih.gov
- Hirsch KR, et al. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. J Diet Suppl 2017;14(1):42-53, 2017-01-02. pubmed.ncbi.nlm.nih.gov
- Kang HJ, et al. Cordyceps militaris enhances cell-mediated immunity in healthy Korean men. J Med Food 2015;18(10):1164-72, 2015-10. pubmed.ncbi.nlm.nih.gov
- Index Fungorum. Cordyceps sinensis (Berk.) Sacc., record 215164 (accessed October 28, 2026). indexfungorum.org
- Guo M, et al. Efficacy and safety of Bailing Capsule for the treatment of adult primary nephrotic syndrome: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2026;17:1798042 (PMID 42110559), 2026-04-24. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in mushroom: Chaga · Lion's mane · Maitake · Reishi · Shiitake · Turkey tail · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.